Lachnospira sp.

Information

Microbe Identification

Lachnospira sp.

Microbe id: PMDBM2021572
Level: Species
NCBI Taxonomy ID:
Taxonomy Species: Lachnospira sp. [2049031]
Taxonomy Genus: Lachnospira [28050]
Taxonomy Family: Lachnospiraceae [186803]

Interactions between microbe and active substances


ⓘ How do we work out MGCs and BGCs of one specific species?


Metabolic gene clusters of Lachnospira sp.

No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View gutSMASH Detailed Result
Biosynthetic gene clusters of Lachnospira sp.


No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View antiSMASH Detailed Result
Map of Lachnospira sp. distribution in human body and influence of diseases distribution in human body and influence of diseases


ⓘ How do you use the microbe distribution map?
ⓘ How did we get the relative abundance and microbe change in the map?
bodymap Oral Nose Esophagus Stomach Trachea Upper respiratory tract Vagina Blood Urethral Lung Cervix Rectum Skin Duodenum Fallopian tube Fallopian tube Peritoneal fluid Uterus Ear Ovary Ovary Colon Ileum Cecum
Disease id Bodysite Relative abundance (%) Disease name Microbe_change

Relative abundance landscape of Lachnospira sp. in human gut microbiota samples



Abundance lanscape in healthy samples (by patients' age)
Abundance lanscape in healthy samples (by patients' country)
Abundance lanscape in disease samples
⚠ About the relative abundance profile

The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].

Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients?country, or disease type to plot the relative abundance landscape using ggplot2 R package.



Comparative analysis of human gut metagenomes between disease and healthy samples of Lachnospira sp.

Data source: Phenotype comparisons were obtained from GMrepo . We summarized all comparisons that included healthy samples as controls and overlapped with microbes represented in MASI.

Note: LDA scores below 0 indicate taxa enriched in healthy samples, whereas scores above 0 indicate taxa enriched in disease samples.

Disease Project ID LDA score Experiment Type
Kidney Failure, Chronic PRJNA449784🔗-4.46835113241133mNGS
Kidney Failure, Chronic PRJNA648014🔗-4.1666547419107716S
Kidney Failure, Chronic PRJEB65297🔗-3.98038325794548mNGS
Arthritis, Juvenile PRJNA562467🔗-4.151084982789416S
Diabetes Mellitus, Type 2 PRJNA871997🔗-4.0022353086227316S
Diabetes Mellitus, Type 2 PRJDB9608🔗-3.9055384742424716S
Liver Cirrhosis, Alcoholic PRJNA690835🔗-4.3596658902243316S
Diarrhea PRJEB14038🔗-4.65304374623919mNGS
Diarrhea PRJNA317326🔗3.1663726529358416S
Dwarfism PRJNA808649🔗-4.34121354067889mNGS
Colorectal Neoplasms PRJNA1138893🔗-4.60170687232913mNGS
Colorectal Neoplasms PRJEB70916🔗-4.30504075929997mNGS
Colorectal Neoplasms PRJEB46665🔗-4.1966347898749916S
Colorectal Neoplasms PRJNA888860🔗-3.99138065071704mNGS
Colorectal Neoplasms PRJNA763023🔗-3.99112455536878mNGS
Colorectal Neoplasms PRJNA284542🔗-3.9858936878303716S
Colorectal Neoplasms PRJNA464414🔗-3.7659444475309216S
Colorectal Neoplasms PRJNA698923🔗-3.2285273300850416S
Respiratory Syncytial Virus Infections PRJNA579491🔗-3.6916578866503516S
Tuberculosis, Gastrointestinal PRJNA743795🔗-4.1244161627917816S
Lupus Erythematosus, Systemic PRJEB39044🔗-3.3109463355588216S
Mental Disorders PRJNA278793🔗-3.6475248420240416S
Growth Disorders PRJEB39484🔗-3.4882275734634116S
Glioma PRJNA626591🔗-3.7665651094988416S
Parkinson Disease PRJNA742875🔗-3.9902021166415616S
Colitis, Ulcerative PRJEB42155🔗-3.9660855618597mNGS
Colitis, Ulcerative PRJNA813736🔗-3.88865625581509mNGS
Colitis, Ulcerative PRJNA804422🔗-3.7796061512711616S
Colitis, Ulcerative PRJNA917086🔗3.8744813197142616S
Campylobacter Infections PRJNA660443🔗-4.10669083181849mNGS
Spinal Cord Injuries PRJNA861246🔗3.7426582632429816S
Osteoporosis, Postmenopausal PRJNA631117🔗-3.9446509805650416S
Carcinoma, Renal Cell PRJNA842560🔗-4.1749635153851716S
Carcinoma, Hepatocellular PRJNA932948🔗-4.2722378106543mNGS
Carcinoma, Hepatocellular PRJNA872871🔗-3.8579844126038216S
Esophageal Neoplasms PRJNA698746🔗-3.9142743781142616S
Hepatolenticular Degeneration PRJNA1038771🔗-3.7384210180807216S
Feeding and Eating Disorders PRJEB55035🔗3.4992971627788616S
Lymphoma, Large B-Cell, Diffuse PRJNA906033🔗-4.2728678599020916S
Non-alcoholic Fatty Liver Disease PRJNA851946🔗4.0489005030740316S
Leukemia, Myeloid, Acute PRJNA813705🔗-4.12266236939687mNGS
Crohn Disease PRJNA793776🔗-4.56459033838996mNGS
Crohn Disease PRJEB42155🔗-4.19282106122369mNGS
Crohn Disease PRJNA1156939🔗-4.1368404375984716S
Crohn Disease PRJNA813736🔗-3.82134944925528mNGS
Crohn Disease PRJNA429990🔗-3.66471011628212mNGS
Crohn Disease PRJNA398089🔗-3.46886860366158mNGS
Crohn Disease PRJNA993675🔗-3.20945711216862mNGS
Crohn Disease PRJNA820056🔗2.4716215247533516S
Psoriasis PRJNA574485🔗-4.0289637563419916S
Psoriasis PRJNA938297🔗-3.40807369819331mNGS
Mastitis PRJNA667141🔗-4.2074133541445516S
Polycystic Ovary Syndrome PRJNA530971🔗4.55231992678467mNGS
Purpura, Thrombocytopenic, Idiopathic PRJNA531564🔗-3.9522486771658216S
Purpura, Thrombocytopenic, Idiopathic PRJNA858062🔗4.12418116874171mNGS
Meningioma PRJNA626591🔗-3.780998036704816S
Multiple System Atrophy PRJNA386851🔗-4.3203166299013316S
Diabetic Retinopathy PRJNA646010🔗-4.4497197621474616S
Dermatitis, Atopic PRJEB45443🔗4.22682746921744mNGS
Autoimmune Diseases of the Nervous System PRJNA586763🔗4.3070048162082116S
Nephrotic Syndrome PRJNA800189🔗-4.3506653132028216S
Cholangiocarcinoma PRJNA932948🔗-4.332597486616mNGS
Anorexia Nervosa PRJEB38930🔗-3.6038712238139416S
Neuroblastoma PRJEB63351🔗-4.2284904792748mNGS
Neuroblastoma PRJNA716780🔗-4.11144839168175mNGS
Myasthenia Gravis PRJNA688881🔗-3.91789341981486mNGS
Myasthenia Gravis PRJEB41297🔗-3.5574217644943116S
Irritable Bowel Syndrome PRJEB37924🔗-3.92146214622744mNGS
Depressive Disorder, Major PRJNA943232🔗-4.17043331565229mNGS
Gastroesophageal Reflux PRJNA993632🔗3.86557680169555mNGS
Clostridium Infections PRJNA648321🔗-3.50224178836602mNGS
Schistosomiasis japonica PRJNA625383🔗-3.306292870588116S
Pancreatic Neoplasms PRJNA665854🔗3.75123325371005mNGS
Kidney Calculi PRJNA742740🔗-4.03017110342596mNGS
Atrial Fibrillation PRJNA728204🔗-3.6218624062518116S
Liver Cirrhosis PRJNA861246🔗3.4775645488530316S
Cystic Fibrosis PRJNA314903🔗-4.48605041748165mNGS
Anti-N-Methyl-D-Aspartate Receptor Encephalitis PRJNA764676🔗-3.6078516058316416S
HIV Infections PRJNA810567🔗-4.0696039541275516S
Autism Spectrum Disorder PRJNA1037036🔗-3.89255942311107mNGS
Autism Spectrum Disorder PRJNA917543🔗-3.4234385623928716S
Neuromyelitis Optica PRJNA662563🔗-3.7907438912253116S
Inflammatory Bowel Diseases PRJNA1028828🔗-3.8866466946993416S
Inflammatory Bowel Diseases PRJEB13266🔗-3.8416113186607216S
Rhinitis, Allergic PRJNA692671🔗3.7048517450134716S
Rhinitis, Allergic PRJNA718687🔗4.3367996972827816S
Biliary Atresia PRJNA730640🔗-4.08451052696264mNGS
Renal Insufficiency, Chronic PRJEB34855🔗-4.2796786194226616S
Renal Insufficiency, Chronic PRJNA562327🔗-4.2113776305082916S
Renal Insufficiency, Chronic PRJNA949558🔗-4.161954755603216S
Renal Insufficiency, Chronic PRJEB65297🔗-4.02271523675541mNGS
Renal Insufficiency, Chronic PRJNA659589🔗-3.4663479926585316S
Malaria PRJNA642859🔗-3.6967626998378516S
Breast Neoplasms PRJNA658160🔗-3.0631804111055716S
COVID-19 PRJNA624223🔗-4.11605766365257mNGS
COVID-19 PRJDB13214🔗-3.65187924234612mNGS
COVID-19 PRJNA769052🔗-3.6272189011144316S
COVID-19 PRJNA678695🔗-3.1004555460063916S

Microbe-Therapeutic Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of therapeutic substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of therapeutic substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Therapeutic substance that metabolized by Lachnospira sp.



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Therapeutic Substances that affect the Lachnospira sp.



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)


Drug involved metabolizing or transporting reactions that are carried out by Lachnospira sp.

No data available!

ⓘ How do we get these drug reactions?

To obtain the reactions associated with therapeutic substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331] database.
Identifying Drug-Associated Reactions: Next, we extracted all reactions that are linked to therapeutic substances from these reconstructions. This involved filtering and identifying reactions specifically related to drug metabolism and transport.
Linking Reaction to Microbes: Utilizing the identified reaction related genes (UidA, Tdc etc.), we machted the corresponding drug-associated reactions to existing microbes in the reconstructions in AGORA2. We could link the presence of these genes in different microbes to the potential for those microbes to carry out the corresponding drug-related reactions.
Putative Drug Reactions: As a result, the drug reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with therapeutic substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGORA2)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGORA2, allowing access to the original .mat files. For more details, visit the AGORA2 repository.

# Model Download
No records found

Detailed Information of drug reactions

Metabolism
Transport
Drug Substrate Drug Metabolite Gene responsible for the reaction Reaction Description Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Substance Name Gene responsible for the reaction Reaction Description Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Herbal Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of herbal substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of herbal substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Traditional medicines/herbs/herbal compounds that metabolized by Lachnospira sp.


Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Traditional medicines/herbs/herbal compounds that affect the Lachnospira sp.



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)

Microbe-Dietary Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of dietary substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of dietary substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGREDA [Ref:Nature Communications, 12 (2021) 4728]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Dietary Substances alter the abundance of Lachnospira sp.

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)





Dietary substance that metabolized by Lachnospira sp.

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)




Dietary Substance involved metabolizing or transporting reactions that are carried out by Lachnospira sp.

ⓘ How do we get these diet reactions?

To obtain the reactions associated with dietary substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGREDA [Ref:Nature Communications, 12 (2021) 4728] database.
Identifying Diet-Associated Reactions: Next, we extracted all reactions that are linked to dietary substances from these reconstructions. This involved filtering and identifying reactions specifically related to dietary substance metabolism and transport.
Linking Reactions to Microbes: Using the identified related genes (e.g., UidA, Tdc) for each drug metabolite reaction, we matched these reactions to microbes possessing the corresponding genes. This allowed us to link the presence of these genes in different microbes to their potential for carrying out the associated drug-related reactions.
Putative Drug Reactions: As a result, the diet reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with dietary substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGREDA)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGREDA, allowing access to the original .xml files. For more details, visit the AGREDA repository.

# Model View
No records found

Detailed Information of diet reactions

Metabolism
Transport
Diet Substrate Enzyme Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Dietary Substance Name Reaction Name Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Environmental Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of environmental substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of environmental substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Environmental Substances that metabolized by Lachnospira sp.



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Environmental Substances that affect the Lachnospira sp.


Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)
ⓘ Background And User Guideline

Microbe Taxonomy level Species Quorum Sensing (QS) Language QS Language Class Total No. of QS Languages of the Species Reference (PubMed ID)


Diseases associated with the microbe Lachnospira sp.


No data available

Microbiota Site Disease Name Disease Association Class Disease Associated Abundence Change Reference (PubMed ID)



Landscape of Bacteria-Substance-Disease Interaction/Association Network



ⓘ How is the network built?